Optimized gating strategy and supporting flow cytometry data for the determination of the Ki-67 proliferation index in the diagnosis of myelodysplastic syndrome-Reference-Cited by-同舟云学术

Optimized gating strategy and supporting flow cytometry data for the determination of the Ki-67 proliferation index in the diagnosis of myelodysplastic syndrome

Published:2022-04 Issue: Volume:41 Page:107976
ISSN:2352-3409
Container-title:Data in Brief
language:en
Short-container-title:Data in Brief

Author:

Mestrum Stefan G.C.^ORCID,Cremers Eline M.P.,de Wit Norbert C.J.,Drent Roosmarie J.M.,Ramaekers Frans C.S.,Hopman Anton H.N.,Leers Math P.G.

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference5 articles.

1. Integration of the Ki-67 proliferation index into the Ogata score improves its diagnostic sensitivity for low-grade myelodysplastic syndromes;Mestrum;Leuk. Res.,2022

2. Determination of the proliferative fractions in differentiating hematopoietic cell lineages of normal bone marrow;Nies;Cytometry A,2018

3. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes;van Dongen;Leukemia,2012

4. The proliferation index of specific bone marrow cell compartments from myelodysplastic syndromes Is associated with the diagnostic and patient outcome;Matarraz;PLoS One,2012

5. Proliferative activity is disturbed in myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and MDS/MPN diseases. Differences between MDS and MDS/MPN;Mestrum;Cytometry B Clin. Cytom.,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of the gating strategy for Ki-67 and Bcl-2 on the determination of proliferation and anti-apoptosis data by flow cytometry in non-malignant bone marrow aspirates and aspirates from patients with myeloid malignancies;Data in Brief;2023-08

2. Comparative diagnostic accuracy between simplified and original flow cytometric gating strategies for peripheral blood neutrophil myeloperoxidase expression in ruling out myelodysplastic syndromes;PLOS ONE;2022-11-18

3. The Proliferation Index of Erythroid Cells Predicts the Development of Transfusion-dependence in Myelodysplastic Syndrome Patients With Mildly Reduced Hemoglobin Levels at Initial Diagnosis;HemaSphere;2022-11-09